Reuters logo
BRIEF-Nexstim gains FDA clearance for NBT system
November 13, 2017 / 1:08 PM / in 8 days

BRIEF-Nexstim gains FDA clearance for NBT system

Nov 13 (Reuters) - NEXSTIM OYJ:

* REG-NEXSTIM GAINS FDA CLEARANCE TO COMMERCIALISE ITS NBT® SYSTEM IN THE US FOR THE TREATMENT OF DEPRESSION

* ‍INTENDS TO BEGIN MARKETING AND SALES OF ITS NBT SYSTEM IN US DURING H1 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below